Complex Effects of Naturally Occurring Mutations in the JAK3 Pseudokinase Domain: Evidence for Interactions between the Kinase and Pseudokinase Domains
- 1 February 2000
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 20 (3) , 947-956
- https://doi.org/10.1128/mcb.20.3.947-956.2000
Abstract
The structure of Janus kinases (JAKs) is unique among protein tyrosine kinases in having tandem, nonidentical kinase and pseudokinase domains. Despite its conservation in evolution, however, the function of the pseudokinase domain remains poorly understood. Lack of JAK3 expression results in severe combined immunodeficiency (SCID). In this study, we analyze two SCID patients with mutations in the JAK3 pseudokinase domain, which allows for protein expression but disrupts the regulation of the kinase activity. Specifically, these mutant forms of JAK3 had undetectable kinase activity in vitro but were hyperphosphorylated both in patients' Epstein-Barr virus-transformed B cells and when overexpressed in COS7 cells. Moreover, reconstitution of cells with these mutants demonstrated that, although they were constitutively phosphorylated basally, they were unable to transmit cytokine-dependent signals. Further analysis showed that the isolated catalytic domain of JAK3 was functional whereas either the addition of the pseudokinase domain or its deletion from the full-length molecule reduced catalytic activity. Through coimmunoprecipitation of the isolated pseudokinase domain with the isolated catalytic domain, we provide the first evidence that these two domains interact. Furthermore, whereas the wild-type pseudokinase domain modestly inhibited kinase domain-mediated STAT5 phosphorylation, the patient-derived mutants markedly inhibited this phosphorylation. We thus conclude that the JAK3 pseudokinase domain is essential for JAK3 function by regulating its catalytic activity and autophosphorylation. We propose a model in which this occurs via intramolecular interaction with the kinase domain and that increased inhibition of kinase activity by the pseudokinase domain likely contributes to the disease pathogenesis in these two patients.Keywords
This publication has 47 references indexed in Scilit:
- JAKS AND STATS: Biological ImplicationsAnnual Review of Immunology, 1998
- An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STATOncogene, 1997
- Three-dimensional structure of the tyrosine kinase c-SrcNature, 1997
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- Developmental defects of lymphoid cells in Jak3 kinase-deficient miceImmunity, 1995
- Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid DevelopmentScience, 1995
- Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3Science, 1995
- Jak-STAT Signaling Induced by the v- abl oncogeneScience, 1995
- Identification and purification of human stat proteins activated in response to interleukin-2Immunity, 1995
- Distinct Domains of the Protein Tyrosine Kinase tyk2 Required for Binding of Interferon-α/β and for Signal TransductionJournal of Biological Chemistry, 1995